{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:53:46Z","timestamp":1775073226410,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[1997,12,18]]},"published-print":{"date-parts":[[1998,5,1]]},"abstract":"<jats:p>\n                  <jats:italic>Background<\/jats:italic>\u2014Liver\/kidney microsomal antibody type 1 (LKM1) and liver cytosol antibody type 1 (LC1) are the serological markers of type 2 autoimmune hepatitis (AIH).<\/jats:p>\n               <jats:p>\n                  <jats:italic>Aims<\/jats:italic>\u2014Since LKM1 and LC1 react against two distinct liver specific autoantigens (cytochrome P450IID6 (CYP2D6) and a 58 kDa cytosolic polypeptide respectively), the aim was to see whether LKM1 and LC1 concentrations correlate with liver disease activity.<\/jats:p>\n               <jats:p>\n                  <jats:italic>Patients<\/jats:italic>\u2014Twenty one patients with type 2 AIH were studied.<\/jats:p>\n               <jats:p>\n                  <jats:italic>Methods<\/jats:italic>\u2014All sera were tested by indirect immunofluorescence, counterimmunoelectrophoresis, and immunoblotting visualised by enhanced chemiluminescence. To evaluate LKM1 and LC1 levels, the 50 kDa microsomal reactivity (corresponding to CYP2D6) and the 58 kDa cytosolic reactivity were quantified by densitometric analysis.<\/jats:p>\n               <jats:p>\n                  <jats:italic>Results<\/jats:italic>\u2014Seven patients were positive for LKM1, nine for LC1, and five for both. Serial serum samples at onset and during immunosuppressive treatment were analysed in 13 patients (four positive for LKM1, six positive for LC1 and three positive for both). During remission, LKM1 concentration remained essentially unchanged in six of seven patients, and decreased in only one. Conversely, in two of nine patients, LC1 was completely lost, and, in the remaining seven, LC1 concentration was reduced by more than 50%. After immunosuppression tapering or withdrawal, flare ups of liver necrosis ensued with increasing LC1 concentration, but not LKM1.<\/jats:p>\n               <jats:p>\n                  <jats:italic>Conclusions<\/jats:italic>\u2014LC1 concentration, at variance with that of LKM1, parallels liver disease activity, and its participation in the pathogenic mechanisms of liver injury can be hypothesised.<\/jats:p>","DOI":"10.1136\/gut.42.5.721","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T12:46:12Z","timestamp":1277901972000},"page":"721-726","source":"Crossref","is-referenced-by-count":103,"title":["Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis"],"prefix":"10.1136","volume":"42","author":[{"given":"L","family":"Muratori","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cataleta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Muratori","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lenzi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F B","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1998,5,1]]},"reference":[{"key":"2025090713082089000_42.5.721.1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02065434"},{"key":"2025090713082089000_42.5.721.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604043341406"},{"key":"2025090713082089000_42.5.721.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80880-0"},{"key":"2025090713082089000_42.5.721.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840070626"},{"key":"2025090713082089000_42.5.721.5","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view.","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2025090713082089000_42.5.721.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250308"},{"key":"2025090713082089000_42.5.721.7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2.","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"2025090713082089000_42.5.721.8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2008-1040438","article-title":"Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance.","volume":"11","author":"Manns","year":"1991","journal-title":"Semin Liver Dis"},{"key":"2025090713082089000_42.5.721.9","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230519"},{"key":"2025090713082089000_42.5.721.10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.3.406"},{"key":"2025090713082089000_42.5.721.11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0016-5085(93)90853-5","article-title":"Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies.","volume":"104","author":"Loeper","year":"1993","journal-title":"Gastroenterology"},{"key":"2025090713082089000_42.5.721.12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.1993.tb03409.x","article-title":"Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.","volume":"92","author":"Yamamoto","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2025090713082089000_42.5.721.13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2249.1993.tb03406.x","article-title":"Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6.","volume":"92","author":"Vergani","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2025090713082089000_42.5.721.14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis.","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"2025090713082089000_42.5.721.15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.5.749"},{"key":"2025090713082089000_42.5.721.16","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(95)90408-5"},{"key":"2025090713082089000_42.5.721.17","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(95)00192-X"},{"key":"2025090713082089000_42.5.721.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180435"},{"key":"2025090713082089000_42.5.721.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.21.8256"},{"key":"2025090713082089000_42.5.721.20","unstructured":"Abuaf N Johanet C Soulie E (1993) Anti-liver cytosol antibodies in hepatology: autoimmune hepatitis, viral hepatitis C and graft-versus-host disease. in Immunology and liver Falk Symposium 70. eds Meyer zum B\u00fcschenfelde KH Hoofnagle JH Manns M (Kluwer Academic Publishers, London), pp 215\u2013226."},{"key":"2025090713082089000_42.5.721.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80477-1"},{"key":"2025090713082089000_42.5.721.22","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91001-O"},{"key":"2025090713082089000_42.5.721.23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115707"},{"key":"2025090713082089000_42.5.721.24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJM197603112941103","article-title":"Detection of a liver membrane autoantibody in HBsAg-negative chronic active hepatitis.","volume":"294","author":"Hopf","year":"1976","journal-title":"N Engl J Med"},{"key":"2025090713082089000_42.5.721.25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hep.1840110414","article-title":"Autoantibodies to isolated human hepatocyte plasma membranes in chronic active hepatitis. II. Specificity of antibodies.","volume":"11","author":"Swanson","year":"1990","journal-title":"Hepatology"},{"key":"2025090713082089000_42.5.721.26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.1840120408","article-title":"Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide.","volume":"12","author":"Toda","year":"1990","journal-title":"Hepatology"},{"key":"2025090713082089000_42.5.721.27","first-page":"89","article-title":"Liver-specific antigens, purification and characterization.","volume":"10","author":"Meyer zum B\u00fcschenfelde","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"2025090713082089000_42.5.721.28","first-page":"347","article-title":"Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver-specific membrane lipoprotein (LSP).","volume":"55","author":"McFarlane","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"2025090713082089000_42.5.721.29","unstructured":"McFarlane BM (1996) Hepatocellular membrane antigens. in Medical Intelligence Unit. Molecular basis of autoimmune hepatitis. eds McFarlane IG Williams R (RG Landes Company, Austin), pp 75\u2013104."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.42.5.721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T20:08:32Z","timestamp":1757275712000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.42.5.721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,1]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1998,5,1]]},"published-print":{"date-parts":[[1998,5,1]]}},"alternative-id":["10.1136\/gut.42.5.721"],"URL":"https:\/\/doi.org\/10.1136\/gut.42.5.721","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5,1]]}}}